European Archives - Page 114 of 995 - European Medical Journal

Optimising Methotrexate for Arthritis

Listen to three experts attending EULAR 2024, who provide their recommendations on how to optimise methotrexate therapy use across various arthritis types.

Patient Perspectives of Navigating Life with Primary Biliary Cholangitis

Transplant hepatologist Eleonora De Martin and patient advocate Ingo van Thiel, co-host this bonus episode to support the continuing education of healthcare professionals working with primary biliary cholangitis. NX-GBL-LNR-AUDI-240001 | May 2024

Primary Parotid Tuberculosis Presenting as a Malignancy

Tuberculosis is a well-known endemic disease in India; however, extra-pulmonary tuberculosis in the form of single parotid gland…

Webinar Series: Keep up to date with the genomic profiling in precision oncology

Sign up to three educational webinars that will cover the latest developments in the precision medicine landscape in non-small cell lung cancer and focus on the key role of next-generation sequencing based biomarker profiling.

SHAM-PVI Trial Confirms Efficacy of Ablation Procedure for Atrial Fibrillation: ESC 2024

ESC 2024: The SHAM-PVI trial confirms that catheter ablation significantly reduces atrial fibrillation burden and improves quality of life compared to a sham treatment.

Optical Coherence Tomography for Stent Guidance Improves Outcomes in Complex PCI Cases: ESC 2024

ESC 2024: OCT-guided PCI in complex lesions reduced cardiac risks by 38% and spontaneous MI by 64% versus angiography, according to the OCCUPI trial.

Wearable ECG Device for Atrial Fibrillation Screening: ESC 2024

Atrial fibrillation screening using a 14-day wearable heart monitor patch significantly increased diagnoses compared to usual care, according to research presented at ESC 2024.

Could AI Diagnose Coronary Artery Disease? ESC 2024

The PROTEUS trial, presented at ESC 2024, evaluated the effectiveness of AI in standardizing clinician decision-making during stress echocardiography for coronary artery disease

stamp of approval

Second mpox vaccine wins FDA approval

The FDA has formally approved Emergent BioSolutions’ smallpox and mpox vaccine for use in preventing the virus in people at high risk of infection.

Common Antibiotics Linked to Risk of Life-Threatening Reactions

New study shows sulfonamides and cephalosporins carry the highest risk for serious cutaneous adverse drug reactions among antibiotics, particularly in older adults.